Evergy's adjusted EPS is projected to grow at an 8.7% annual rate, outpacing its 10-year CAGR. Read why EVRG stock is ...

Cogent Biosciences is positioned to build a niche KIT-mutant franchise, leveraging bezuclastinib across three pivotal ...

Background Thoracic aortic aneurysms (TAA) are predominantly degenerative. Non-infectious inflammatory aortitis, including ...

A variety of chapter 11 plan provisions limiting claims against nondebtors have long been used to promote confirmation efforts. Such ...